Literature DB >> 20732297

Approaches for targeting mitochondria in cancer therapy.

Gerard G M D'Souza1, Mayura A Wagle, Vaibhav Saxena, Anee Shah.   

Abstract

The recognition of the role that mitochondria play in human health and disease is evidenced by the emergence in recent decades of a whole new field of "Mitochondrial Medicine". Molecules located on or inside mitochondria are considered prime pharmacological targets and a wide range of efforts are underway to exploit these targets to develop targeted therapies for various diseases including cancer. However the concept of targeting, while seemingly simple in theory, has multiple subtly different practical approaches. The focus of this article is to highlight these differences in the context of a discussion on the current status of various mitochondria-targeted approaches to cancer therapy.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732297     DOI: 10.1016/j.bbabio.2010.08.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  25 in total

Review 1.  Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.

Authors:  Gantumur Battogtokh; Yeon Su Choi; Dong Seop Kang; Sang Jun Park; Min Suk Shim; Kang Moo Huh; Yong-Yeon Cho; Joo Young Lee; Hye Suk Lee; Han Chang Kang
Journal:  Acta Pharm Sin B       Date:  2018-05-18       Impact factor: 11.413

2.  Long-Circulating Amphiphilic Doxorubicin for Tumor Mitochondria-Specific Targeting.

Authors:  Jingchao Xi; Meng Li; Benxin Jing; Myunggi An; Chunsong Yu; Cameron B Pinnock; Yingxi Zhu; Mai T Lam; Haipeng Liu
Journal:  ACS Appl Mater Interfaces       Date:  2018-12-06       Impact factor: 9.229

Review 3.  Harnessing system models of cell death signalling for cytotoxic chemotherapy: towards personalised medicine approaches?

Authors:  Heinrich J Huber; Ross G McKiernan; Jochen H M Prehn
Journal:  J Mol Med (Berl)       Date:  2014-01-30       Impact factor: 4.599

4.  A Multi-Mitochondrial Anticancer Agent that Selectively Kills Cancer Cells and Overcomes Drug Resistance.

Authors:  Yong Bo Peng; Zi Long Zhao; Teng Liu; Guo Jian Xie; Cheng Jin; Tang Gang Deng; Yang Sun; Xiong Li; Xiao Xiao Hu; Xiao Bing Zhang; Mao Ye; Wei Hong Tan
Journal:  ChemMedChem       Date:  2017-01-18       Impact factor: 3.466

5.  The clinical impact and biological mechanisms of skeletal muscle aging.

Authors:  Zaira Aversa; Xu Zhang; Roger A Fielding; Ian Lanza; Nathan K LeBrasseur
Journal:  Bone       Date:  2019-05-22       Impact factor: 4.398

6.  In vivo selective cancer-tracking gadolinium eradicator as new-generation photodynamic therapy agent.

Authors:  Tao Zhang; Rongfeng Lan; Chi-Fai Chan; Ga-Lai Law; Wai-Kwok Wong; Ka-Leung Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-01       Impact factor: 11.205

7.  CHOP THERAPY INDUCED MITOCHONDRIAL REDOX STATE ALTERATION IN NON-HODGKIN'S LYMPHOMA XENOGRAFTS.

Authors:  H N Xu; H Zhao; T A Mir; S C Lee; M Feng; R Choe; J D Glickson; L Z Li
Journal:  J Innov Opt Health Sci       Date:  2013-04

8.  Mapping the redox state of CHOP-treated non-Hodgkin's lymphoma xenografts in mice.

Authors:  He N Xu; Tahreem A Mir; Seung-Cheol Lee; Min Feng; Namisa Farhad; Regine Choe; Jerry D Glickson; Lin Z Li
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

9.  Centrifugation-Free Magnetic Isolation of Functional Mitochondria Using Paramagnetic Iron Oxide Nanoparticles.

Authors:  Bhabatosh Banik; Shanta Dhar
Journal:  Curr Protoc Cell Biol       Date:  2017-09-01

10.  The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells.

Authors:  Birte Plitzko; Elizabeth N Kaweesa; Sandra Loesgen
Journal:  J Biol Chem       Date:  2017-10-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.